EDITORIAL SECTION

Articles

Beyond Trial Completion: Post-Trial Responsibilities and Effective Dissemination of Clinical Research

Clinical trials are the cornerstone of evidencebased medicine and pharmaceutical innovation Through the systematic evaluation of interventions they provide the evidence required to assess efficacy safety and value for patients and healthcare systems However the completion of participant followup does not signify the completion of a trials ethical and scientific obligations

Using Mass Spectrometry as Quality Control in Medicinal Cannabis

Cannabis plants contain a wide variety of complex compounds including phytocannabinoids terpenoids and flavonoids found mainly in the inflorescences Major phytocannabinoids like CBD and THC have beneficial effects on human health

How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management

The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously

mRNA Technology: Unlocking New Possibilities In Therapeutics Beyond Vaccines

In the last few years the mRNA has emerged as a discovery of the century in what concerns biotechnology and medicine Although it has emerged on the global level during the search for COVID vaccines it is used in many other ways Scientists and big pharmacy companies are now investigating virtually all possible uses of mRNA from highly targeted treatments to diseases that had no cure before

Smarter, Faster, Cheaper: The Quiet Revolution in Pharma's First Half of 2026

If you took a step back to look at the pharmaceutical industry during the first six months of one thing became obvious very quickly The old rules of global drug manufacturing were quietly rewritten For decades major lowcost production centers were viewed mostly as highvolume factories for basic

Multi-Omics Integration: Accelerating Precision Drug Development

The economics of pharmaceutical RD are dominated by a single line item that never appears on a balance sheet the programmes that did not work Only about one clinical programme in ten reaches approval and the cost of the nine that do not is carried entirely by the one that does

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys